Clinical implications of assessment of apixaban levels in elderly atrial fibrillation patients: J-ELD AF registry sub-cohort analysis

ConclusionsA high trough apixaban level in patients indicated for standard dose was not associated with adverse events, while a high apixaban level in patients indicated for a reduced dose was associated with bleeding requiring hospitalization.

http://link.springer.com/10.1007/s00228-020-02896-y

Source: European Journal of Clinical Pharmacology - May 24, 2020 Category: Drugs & Pharmacology Source Type: research